ENTITY
Sido Muncul

Sido Muncul (SIDO IJ)

130
Analysis
Health Care • Indonesia
Sido Muncul is an Indonesian company specializing in herbal medicine, pharmaceuticals, and food and beverage products. Its product categories include herbal medicine and supplements, such as the well-known Tolak Angin, along with food and beverages, and pharmaceutical items. The company is headquartered in Semarang, Central Java, Indonesia, and was established in 1940.
more
bearish•Sido Muncul
•09 May 2024 17:12

Sido Muncul (SIDO): Take Your Win First

​After a poor year last year, SIDO operating numbers come back in Q4 23 and even more so in Q1 24 due to revenue growth and cost cutting exercise....

Logo
1.1k Views
Share
bullish•Sido Muncul
•30 Apr 2024 09:02•Broker

Sido Muncul (SIDO IJ) - 1Q24 Earnings Beat on Solid Volume and Margins

On the back of solid 1Q24 revenue (driven mostly by volume) and higher margins, SIDO booked brisk 1Q24 net profit growth of 30% yoy.

Logo
424 Views
Share
bearish•Sido Muncul
•23 Feb 2024 19:58•Broker

Sido Muncul (SIDO IJ) - 4Q23 Earnings Beat and Rosy Outlook, but Already Priced In

SIDO guided for >10% yoy top and bottom line growth in FY24, expected to be supported by exports, new products & higher outlet...

Logo
566 Views
Share
•08 Jan 2024 06:10

LQ45 Index Rebalance Preview (Jan): Reading the Tea Leaves

There could be 5 potential changes for the LQ45 Index in January. The potential adds have performed well while the potential deletes are trading...

Logo
894 Views
Share
bullish•Sido Muncul
•24 Nov 2023 19:58•Broker

Sido Muncul (SIDO.IJ) - A Steadier Growth Prospect in FY24

Following SIDO’s sluggish sales volume in 9M23, we lowered our FY23/ FY24F net profit estimate by -13.5%/ -12.4%. Nonetheless, we think the worst...

Logo
616 Views
Share
x